{"id":"W4406158969","doi":"10.1080/17474086.2025.2450223","title":"Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review","year":2025,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Occupational Cancer Research Centre; Cancer Care Ontario","funders":"Pfizer","keywords":"Medicine; Refractory (planetary science); Lymphoblastic Leukemia; Gemtuzumab ozogamicin; Oncology; Intensive care medicine; Leukemia; Internal medicine; Pediatrics; Stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007337205,0.001444646,0.009548421,0.01266545,0.0006017293,0.002961739,0.002041669,0.001836379,0.004453715],"category_scores_gemma":[0.03240679,0.0009083758,0.007496878,0.01169392,0.0009498083,0.002681649,0.001488512,0.0009818156,0.0003348824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003420839,"about_ca_system_score_gemma":0.01052109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006199935,"about_ca_topic_score_gemma":0.01582095,"domain_scores_codex":[0.9933891,0.002043301,0.002933308,0.000530726,0.0009246048,0.000178875],"domain_scores_gemma":[0.9733589,0.01778619,0.006338307,0.0003219154,0.001870229,0.000324426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001922801,0.00001000451,0.0007302274,0.9690304,0.006385267,0.00006898624,0.0001366197,0.00006786737,0.0001056868,0.0001470604,0.001042812,0.02208268],"study_design_scores_gemma":[0.0002716581,0.0001543033,0.003133007,0.9076191,0.07597446,0.0003277805,0.0003113504,0.00008662782,0.0001435496,0.0003759465,0.01156005,0.00004224662],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001667855,0.9961798,0.0001879252,0.0004683768,0.00008686886,0.0004213241,0.0007188044,0.000009994946,0.0002590281],"genre_scores_gemma":[0.01986981,0.9768588,0.0009559899,0.0008058185,0.00009280918,0.0007934525,0.0005050523,0.000008031155,0.0001101814],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01266545,"threshold_uncertainty_score":0.03880328,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02011902196243325,"score_gpt":0.3459785393528343,"score_spread":0.3258595173904011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}